109628-14-0Br.CCSc1nc2ccccc2[nH]1BKUKXOMYGPYFJJ-UHFFFAOYSA-N2-mercaptobenzimidazole deriv.; alkylating agent and mutagen antagonist
109628-14-0、63513-71-3DTXSID00212924Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.
Drugs used to prevent SEIZURES or reduce their severity.
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…